JJ gets it! All India. All day.

Discussion in 'Novartis' started by Anonymous, Apr 15, 2014 at 10:28 PM.

Tags: Add Tags

  1. Anonymous

    Anonymous Guest

    "The company plans to cut 500 jobs in Switzerland from R&D and administrative functions, while hiring another 500 or so Swiss workers for different positions in the pharma business, as well as generic drugs and over-the-counter products."

    "The company plans to cut or shuffle up to 4,000 jobs in its pharma business, . . . . "

    This article talks about "R&D and Administrative functions" but if combined with the "4,000" number you can extrapolate what it means for all of Novartis Pharma. If the emphasis is changing from branded drugs in Pharma to generics and OTC then the recent moves in regards to the Pharma Sales Reps is just the beginning. The long steady slope to a US Pharma market just like one in Europe due to Obamacare is starting.
     
  2. Anonymous

    Anonymous Guest

    this is old news.

    you want "hasn't happened yet" news?

    1. there are limited to zero drug sales(wo)men in < 5 years.
    2. all commodity functions are outsourced.
    3. divisions merge and collapse into one brand name.
    4. internal org structure is group, r&d, and product/market teams.
    5. product manager, clinical trial manager, and discovery specialist are the most valued roles in the company.